BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23769673)

  • 1. TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function.
    Wang J; Park JS; Wei Y; Rajurkar M; Cotton JL; Fan Q; Lewis BC; Ji H; Mao J
    Mol Cell; 2013 Jul; 51(2):211-25. PubMed ID: 23769673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIB2 inhibits Wnt/β-Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β-TrCP, COP1 and Smurf1, in liver cancer cells.
    Xu S; Tong M; Huang J; Zhang Y; Qiao Y; Weng W; Liu W; Wang J; Sun F
    FEBS Lett; 2014 Nov; 588(23):4334-41. PubMed ID: 25311538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
    Hu BS; Xiong SM; Li G; Li JP
    Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired phosphorylation and ubiquitination by p70 S6 kinase (p70S6K) and Smad ubiquitination regulatory factor 1 (Smurf1) promote tribbles homolog 2 (TRIB2) stability and carcinogenic property in liver cancer.
    Wang J; Zhang Y; Weng W; Qiao Y; Ma L; Xiao W; Yu Y; Pan Q; Sun F
    J Biol Chem; 2013 Nov; 288(47):33667-33681. PubMed ID: 24089522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide production upregulates Wnt/β-catenin signaling by inhibiting Dickkopf-1.
    Du Q; Zhang X; Liu Q; Zhang X; Bartels CE; Geller DA
    Cancer Res; 2013 Nov; 73(21):6526-37. PubMed ID: 24008318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
    Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
    World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα.
    Grandinetti KB; Stevens TA; Ha S; Salamone RJ; Walker JR; Zhang J; Agarwalla S; Tenen DG; Peters EC; Reddy VA
    Oncogene; 2011 Jul; 30(30):3328-35. PubMed ID: 21399661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L; Li X; Li H; Chen H; Liu H
    Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells.
    Zanella F; Renner O; García B; Callejas S; Dopazo A; Peregrina S; Carnero A; Link W
    Oncogene; 2010 May; 29(20):2973-82. PubMed ID: 20208562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
    Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
    Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.
    Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L
    PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
    Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
    Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB2 and the ubiquitin proteasome system in cancer.
    Salomè M; Campos J; Keeshan K
    Biochem Soc Trans; 2015 Oct; 43(5):1089-94. PubMed ID: 26517929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.
    Meier-Abt F; Milani E; Roloff T; Brinkhaus H; Duss S; Meyer DS; Klebba I; Balwierz PJ; van Nimwegen E; Bentires-Alj M
    Breast Cancer Res; 2013 Apr; 15(2):R36. PubMed ID: 23621987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.